PENTOXIFYLLINE

PENTOXIFYLLINE was reported 4347 times

PENTOXIFYLLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 235 0.2182
1 NAEVOID MELANOMA 6 0.1463
2 PLEURAL MASS 7 0.1148
3 TYPE 2 LEPRA REACTION 20 0.1070
4 BODY TINEA 56 0.1000
5 RADIOTHERAPY TO BRAIN 6 0.0968
6 AORTIC BRUIT 6 0.0625
7 BIOPSY LYMPH GLAND 6 0.0612
8 URINARY TRACT DISORDER 210 0.0466
9 VENTRICULAR ENLARGEMENT 6 0.0341
10 HAEMORRHAGIC STROKE 261 0.0334
11 INHIBITORY DRUG INTERACTION 52 0.0328
12 ENDARTERECTOMY 6 0.0268
13 MYOCARDIAL NECROSIS 6 0.0258
14 INFECTION SUSCEPTIBILITY INCREASED 56 0.0256
15 PENILE HAEMATOMA 6 0.0255
16 CHILLBLAINS 6 0.0230
17 ATRIAL ENLARGEMENT 6 0.0221
18 PENILE CONTUSION 10 0.0209
19 OCULAR DISCOMFORT 234 0.0208
20 RIGHT VENTRICULAR ENLARGEMENT 6 0.0187
21 GENERALISED OEDEMA 225 0.0182
22 HEART VALVE STENOSIS 6 0.0166
23 PNEUMONIA MYCOPLASMAL 12 0.0151
24 SKIN FIBROSIS 7 0.0145
25 JOINT CONTRACTURE 15 0.0140
26 OESOPHAGEAL DILATATION 6 0.0136
27 HEAD DISCOMFORT 234 0.0132
28 LUNG DIFFUSION TEST DECREASED 5 0.0125
29 PERIPHERAL ARTERY OCCLUSION 16 0.0114
30 ALTERED STATE OF CONSCIOUSNESS 241 0.0111
31 OTITIS MEDIA ACUTE 8 0.0109
32 INTERMITTENT CLAUDICATION 17 0.0107
33 GLUCOSE TOLERANCE IMPAIRED 63 0.0106
34 PROTHROMBIN LEVEL DECREASED 10 0.0106
35 PENILE SWELLING 13 0.0106
36 SPINAL EPIDURAL HAEMATOMA 6 0.0102
37 HAEMATEMESIS 249 0.0098
38 INFANTILE APNOEA 8 0.0098
39 SYSTEMIC SCLERODERMA 7 0.0096
40 FINGER AMPUTATION 7 0.0095
41 FRACTURE OF PENIS 5 0.0095
42 SEDATION COMPLICATION 24 0.0094
43 PHOTOPHOBIA 176 0.0093
44 TELANGIECTASIA 9 0.0093
45 PRESYNCOPE 219 0.0090
46 PERIPHERAL VASCULAR DISORDER 46 0.0089
47 PERIPHERAL ISCHAEMIA 35 0.0086
48 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
49 MYCOBACTERIUM ABSCESSUS INFECTION 6 0.0084
50 ASCITES 245 0.0083
51 DIPLOPIA 211 0.0081
52 HILAR LYMPHADENOPATHY 7 0.0080
53 ALLERGIC COUGH 6 0.0078
54 PURPURA 69 0.0078
55 DEAFNESS BILATERAL 13 0.0076
56 BRONCHIAL CARCINOMA 6 0.0076
57 NEPHROGENIC SYSTEMIC FIBROSIS 23 0.0076
58 EXTREMITY NECROSIS 13 0.0074
59 FEMORAL NECK FRACTURE 38 0.0074
60 SKIN INDURATION 15 0.0072
61 DISCHARGE 10 0.0072
62 HAEMATURIA 238 0.0069
63 CARDIOACTIVE DRUG LEVEL INCREASED 9 0.0068
64 HYPERPLASIA 6 0.0067
65 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 5 0.0066
66 MULTIPLE DRUG THERAPY 5 0.0066
67 BRADYCARDIA NEONATAL 8 0.0064
68 HYPERLIPIDAEMIA 76 0.0064
69 CARDIO-RESPIRATORY ARREST 261 0.0062
70 BLINDNESS 251 0.0062
71 ALLODYNIA 7 0.0060
72 LUNG HYPERINFLATION 5 0.0058
73 SCLERODERMA 21 0.0058
74 NECROTISING MYOSITIS 5 0.0058
75 COMA 269 0.0056
76 ANOGENITAL WARTS 5 0.0056
77 CALCIPHYLAXIS 10 0.0054
78 MITRAL VALVE PROLAPSE 9 0.0054
79 HYPERPARATHYROIDISM SECONDARY 13 0.0052
80 LYMPHOCYTOSIS 11 0.0051
81 CLOSTRIDIUM TEST POSITIVE 11 0.0050
82 TINNITUS 225 0.0049
83 HYPERTENSIVE HEART DISEASE 9 0.0048
84 ARTHROPOD STING 8 0.0048
85 NEPHROGENIC ANAEMIA 22 0.0047
86 IMPAIRED QUALITY OF LIFE 68 0.0047
87 LEFT ATRIAL DILATATION 6 0.0047
88 EYE PAIN 255 0.0045
89 RENAL ARTERY STENOSIS 6 0.0044
90 RESPIRATORY DISORDER NEONATAL 7 0.0043
91 LUMBAR RADICULOPATHY 5 0.0043
92 DILATATION ATRIAL 5 0.0043
93 BRONCHIAL OBSTRUCTION 6 0.0043
94 METABOLIC SYNDROME 7 0.0043
95 PRERENAL FAILURE 6 0.0043
96 SENSE OF OPPRESSION 5 0.0042
97 DEMENTIA ALZHEIMER'S TYPE 7 0.0042
98 MYCOBACTERIAL INFECTION 7 0.0041
99 BUNDLE BRANCH BLOCK LEFT 17 0.0040
100 EPICONDYLITIS 6 0.0040
101 PENILE PAIN 12 0.0039
102 CAROTID ARTERY DISEASE 5 0.0039
103 CYTOMEGALOVIRUS COLITIS 9 0.0039
104 DIASTOLIC DYSFUNCTION 12 0.0039
105 LOBAR PNEUMONIA 7 0.0038
106 HIRSUTISM 5 0.0038
107 JAW FRACTURE 8 0.0037
108 RHONCHI 5 0.0036
109 SKIN TIGHTNESS 17 0.0036
110 VEIN RUPTURE 6 0.0036
111 POOR QUALITY SLEEP 77 0.0036
112 SKIN HYPERTROPHY 10 0.0036
113 PERSONALITY DISORDER 9 0.0034
114 CAROTID ARTERY STENOSIS 12 0.0034
115 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 14 0.0034
116 INSULIN RESISTANCE 7 0.0034
117 ANGIOPLASTY 5 0.0033
118 METABOLIC ENCEPHALOPATHY 10 0.0033
119 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
120 POOR PERIPHERAL CIRCULATION 14 0.0033
121 PLEURITIC PAIN 9 0.0033
122 NECROSIS 18 0.0032
123 TACHYCARDIA 283 0.0032
124 DIABETIC NEPHROPATHY 7 0.0032
125 INFECTED SKIN ULCER 6 0.0032
126 DERMATOMYOSITIS 8 0.0032
127 LEG AMPUTATION 13 0.0032
128 CARCINOEMBRYONIC ANTIGEN INCREASED 6 0.0031
129 PULMONARY ARTERIAL PRESSURE INCREASED 5 0.0031
130 QUADRIPARESIS 5 0.0030
131 CEREBROVASCULAR DISORDER 9 0.0030
132 DIABETIC RETINOPATHY 10 0.0029
133 FIBROSIS 9 0.0029
134 SKIN ULCER 75 0.0029
135 IMPAIRED WORK ABILITY 62 0.0029
136 ORAL HERPES 56 0.0029
137 OESOPHAGEAL ULCER 11 0.0029
138 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
139 GANGRENE 17 0.0028
140 VENTRICULAR HYPOKINESIA 9 0.0028
141 VENOOCCLUSIVE DISEASE 7 0.0028
142 SKIN HYPERPIGMENTATION 24 0.0028
143 VENTRICULAR HYPERTROPHY 7 0.0028
144 PYODERMA GANGRENOSUM 10 0.0028
145 PARAPLEGIA 8 0.0028
146 SEPSIS 308 0.0028
147 INTERNATIONAL NORMALISED RATIO DECREASED 11 0.0027
148 CREPITATIONS 8 0.0027
149 LUNG ADENOCARCINOMA 8 0.0027
150 BLOOD BICARBONATE DECREASED 5 0.0026
151 DIABETIC NEUROPATHY 13 0.0026
152 GINGIVAL DISORDER 10 0.0026
153 CHILLS 302 0.0026
154 DYSLIPIDAEMIA 13 0.0026
155 OCCULT BLOOD POSITIVE 5 0.0025
156 SYNCOPE 253 0.0025
157 PULSE ABSENT 12 0.0025
158 LACUNAR INFARCTION 6 0.0025
159 CUSHINGOID 8 0.0025
160 OTITIS MEDIA 8 0.0024
161 TRICUSPID VALVE INCOMPETENCE 19 0.0024
162 INTERNATIONAL NORMALISED RATIO INCREASED 68 0.0024
163 METASTASES TO SPINE 8 0.0024
164 EXCORIATION 6 0.0024
165 AORTIC VALVE INCOMPETENCE 10 0.0023
166 PSEUDOMONAS INFECTION 20 0.0023
167 BLOOD CHLORIDE DECREASED 6 0.0023
168 HYPERSENSITIVITY VASCULITIS 6 0.0023
169 RENAL FAILURE CHRONIC 17 0.0022
170 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
171 AKATHISIA 30 0.0022
172 CELLULITIS 110 0.0022
173 ISCHAEMIA 10 0.0022
174 KLEBSIELLA INFECTION 11 0.0022
175 NEUROLOGICAL DECOMPENSATION 5 0.0022
176 SQUAMOUS CELL CARCINOMA OF SKIN 13 0.0022
177 MITRAL VALVE INCOMPETENCE 24 0.0021
178 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
179 TONGUE OEDEMA 8 0.0021
180 DUODENAL ULCER HAEMORRHAGE 6 0.0021
181 OLIGURIA 13 0.0021
182 POTENTIATING DRUG INTERACTION 7 0.0021
183 END STAGE RENAL DISEASE 38 0.0021
184 HYPOGLYCAEMIC COMA 6 0.0021
185 PREMATURE RUPTURE OF MEMBRANES 5 0.0021
186 CLOSTRIDIAL INFECTION 7 0.0021
187 IRON DEFICIENCY ANAEMIA 19 0.0021
188 ARTERIOSCLEROSIS 19 0.0020
189 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
190 PROTHROMBIN TIME PROLONGED 12 0.0020
191 BASAL CELL CARCINOMA 31 0.0020
192 RETINAL ARTERY OCCLUSION 5 0.0020
193 BONE DENSITY DECREASED 62 0.0020
194 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
195 SKIN DISORDER 65 0.0019
196 AORTIC ARTERIOSCLEROSIS 5 0.0019
197 RENAL TRANSPLANT 7 0.0019
198 VISUAL DISTURBANCE 11 0.0019
199 EOSINOPHILIC PNEUMONIA 6 0.0019
200 RALES 11 0.0019
201 RIGHT VENTRICULAR FAILURE 13 0.0019
202 METASTATIC NEOPLASM 8 0.0019
203 SNORING 7 0.0018
204 NEPHROPATHY 17 0.0018
205 IMMUNE-MEDIATED MYOSITIS 5 0.0018
206 LUNG INFILTRATION 16 0.0018
207 CYTOLYTIC HEPATITIS 6 0.0018
208 ISCHAEMIC STROKE 32 0.0018
209 ARTERIAL OCCLUSIVE DISEASE 14 0.0018
210 NECK MASS 5 0.0018
211 BLOOD PRESSURE INCREASED 270 0.0018
212 VISION BLURRED 241 0.0018
213 CARDIAC VALVE DISEASE 10 0.0017
214 CEREBRAL ISCHAEMIA 9 0.0017
215 BLEPHARITIS 7 0.0017
216 SKIN ATROPHY 10 0.0017
217 SKIN NECROSIS 9 0.0017
218 BLOOD UREA INCREASED 29 0.0017
219 ELECTROLYTE IMBALANCE 20 0.0017
220 BLOOD LACTATE DEHYDROGENASE INCREASED 27 0.0017
221 SQUAMOUS CELL CARCINOMA 16 0.0017
222 CATARACT 100 0.0017
223 MYOCARDIAL ISCHAEMIA 19 0.0017
224 ATELECTASIS 16 0.0017
225 LIP OEDEMA 7 0.0017
226 DIABETIC FOOT 5 0.0016
227 ISCHAEMIC CARDIOMYOPATHY 5 0.0016
228 ATRIAL FLUTTER 13 0.0016
229 MYALGIA 277 0.0016
230 CORONARY ARTERY DISEASE 49 0.0016
231 SUBDURAL HAEMATOMA 23 0.0016
232 IMMOBILE 7 0.0016
233 PERIPHERAL COLDNESS 22 0.0016
234 OSTEOMYELITIS 29 0.0016
235 PULMONARY FUNCTION TEST DECREASED 7 0.0016
236 IRIDOCYCLITIS 5 0.0016
237 TOE AMPUTATION 8 0.0016
238 HYPERKALAEMIA 55 0.0016
239 OESOPHAGEAL DISORDER 6 0.0016
240 LOOSE TOOTH 5 0.0016
241 OPTIC ISCHAEMIC NEUROPATHY 6 0.0015
242 STOMACH DISCOMFORT 8 0.0015
243 CARDIOPULMONARY FAILURE 6 0.0015
244 HYPOVOLAEMIA 9 0.0015
245 HYPERTRIGLYCERIDAEMIA 9 0.0015
246 STEVENS-JOHNSON SYNDROME 34 0.0015
247 PLEURISY 9 0.0015
248 HYPOKINESIA 22 0.0015
249 DRUG INTERACTION 240 0.0015
250 HYPOMAGNESAEMIA 21 0.0015
251 ANGINA PECTORIS 43 0.0015
252 CANDIDIASIS 6 0.0015
253 HEPATITIS CHOLESTATIC 9 0.0015
254 DIABETES MELLITUS INADEQUATE CONTROL 26 0.0015
255 ECCHYMOSIS 10 0.0015
256 CORONARY ARTERY OCCLUSION 20 0.0015
257 INTESTINAL ISCHAEMIA 8 0.0015
258 AORTIC STENOSIS 5 0.0014
259 SWELLING OF EYELID 9 0.0014
260 ANGIOPATHY 8 0.0014
261 INSOMNIA 375 0.0014
262 ABSCESS LIMB 6 0.0014
263 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
264 SOMNOLENCE 282 0.0014
265 ARRHYTHMIA 66 0.0014
266 DECREASED APPETITE 320 0.0014
267 MAJOR DEPRESSION 10 0.0014
268 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
269 PARONYCHIA 6 0.0014
270 MELAENA 30 0.0014
271 HERPES ZOSTER 78 0.0014
272 DECUBITUS ULCER 11 0.0013
273 VENTRICULAR EXTRASYSTOLES 14 0.0013
274 ABDOMINAL PAIN 311 0.0013
275 CYANOSIS 21 0.0013
276 HAEMOGLOBIN INCREASED 6 0.0013
277 HAEMATOMA 34 0.0013
278 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
279 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
280 BRAIN INJURY 13 0.0013
281 ORAL CANDIDIASIS 17 0.0013
282 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
283 EPIGASTRIC DISCOMFORT 5 0.0013
284 FALL 426 0.0013
285 CHRONIC KIDNEY DISEASE 97 0.0013
286 SEASONAL ALLERGY 18 0.0013
287 GASTRIC ULCER HAEMORRHAGE 7 0.0013
288 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 69 0.0013
289 ULCER 20 0.0013
290 CEREBRAL ATROPHY 5 0.0013
291 ECONOMIC PROBLEM 19 0.0013
292 SPINAL OSTEOARTHRITIS 11 0.0013
293 OBSTRUCTION 5 0.0013
294 ENTEROCOCCAL INFECTION 6 0.0012
295 BLOOD POTASSIUM INCREASED 20 0.0012
296 ABDOMINAL PAIN UPPER 253 0.0012
297 SHOCK HAEMORRHAGIC 10 0.0012
298 PERIPHERAL VENOUS DISEASE 5 0.0012
299 GOITRE 5 0.0012
300 CARDIOMEGALY 15 0.0012
301 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
302 HYPOPHOSPHATAEMIA 9 0.0012
303 HYPERURICAEMIA 5 0.0012
304 HYPOKALAEMIA 56 0.0012
305 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
306 RETINAL DETACHMENT 11 0.0012
307 OEDEMA PERIPHERAL 145 0.0012
308 OSTEOPENIA 18 0.0012
309 RENAL FAILURE 157 0.0012
310 NEUROLEPTIC MALIGNANT SYNDROME 14 0.0012
311 ACIDOSIS 9 0.0012
312 ASTHENIA 439 0.0012
313 ONYCHOCLASIS 8 0.0012
314 HAEMATOTOXICITY 11 0.0012
315 HYPOGLYCAEMIA 56 0.0012
316 THERAPY PARTIAL RESPONDER 18 0.0012
317 DYSPNOEA EXERTIONAL 43 0.0011
318 SERUM FERRITIN INCREASED 6 0.0011
319 LARYNGEAL OEDEMA 7 0.0011
320 DUODENAL ULCER 8 0.0011
321 RENAL TUBULAR NECROSIS 11 0.0011
322 PRE-EXISTING CONDITION IMPROVED 7 0.0011
323 HEPATOMEGALY 11 0.0011
324 CARDIOGENIC SHOCK 16 0.0011
325 MYOSITIS 10 0.0011
326 COUGH 312 0.0011
327 PULMONARY HYPERTENSION 23 0.0011
328 HYPERAESTHESIA 9 0.0011
329 EMPHYSEMA 11 0.0011
330 VENTRICULAR TACHYCARDIA 18 0.0011
331 ANOREXIA 14 0.0011
332 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
333 CARDIOMYOPATHY 16 0.0011
334 LOCALISED INFECTION 26 0.0011
335 ROSACEA 5 0.0011
336 ACUTE PULMONARY OEDEMA 6 0.0011
337 GASTROINTESTINAL HAEMORRHAGE 89 0.0011
338 HAEMATOCRIT DECREASED 21 0.0011
339 HEPATOCELLULAR INJURY 15 0.0011
340 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
341 ACUTE MYOCARDIAL INFARCTION 31 0.0011
342 LEUKOCYTOSIS 19 0.0010
343 JOINT RANGE OF MOTION DECREASED 14 0.0010
344 HYPOVOLAEMIC SHOCK 5 0.0010
345 CORONARY ARTERY BYPASS 6 0.0010
346 MULTI-ORGAN FAILURE 18 0.0010
347 HAEMOPTYSIS 29 0.0010
348 BRONCHIECTASIS 7 0.0010
349 SECRETION DISCHARGE 13 0.0010
350 CONTUSION 99 0.0010
351 APNOEA 8 0.0010
352 INFARCTION 7 0.0010
353 ENCEPHALOPATHY 25 0.0010
354 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
355 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
356 ROTATOR CUFF SYNDROME 13 0.0010
357 LARGE INTESTINE POLYP 7 0.0010
358 DELIRIUM 35 0.0010
359 ANEURYSM 5 0.0010
360 HYPOCALCAEMIA 19 0.0010
361 BLOOD PRESSURE INADEQUATELY CONTROLLED 6 0.0010
362 RENAL FAILURE ACUTE 42 0.0010
363 ACUTE RESPIRATORY FAILURE 19 0.0010
364 IMMUNE SYSTEM DISORDER 13 0.0010
365 SKIN LESION 27 0.0010
366 METASTASIS 7 0.0010
367 ORTHOSTATIC HYPOTENSION 17 0.0010
368 EYE HAEMORRHAGE 13 0.0010
369 MENTAL STATUS CHANGES 27 0.0010
370 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
371 CACHEXIA 5 0.0010
372 SPINAL COMPRESSION FRACTURE 8 0.0010
373 BLOOD CREATININE INCREASED 63 0.0010
374 ATRIAL SEPTAL DEFECT 8 0.0010
375 HAEMODIALYSIS 8 0.0010
376 SPUTUM DISCOLOURED 9 0.0009
377 SKIN PLAQUE 8 0.0009
378 GASTRIC ULCER 18 0.0009
379 HEMIPARESIS 16 0.0009
380 DIZZINESS 466 0.0009
381 PROCTALGIA 6 0.0009
382 PEMPHIGOID 7 0.0009
383 BLOOD MAGNESIUM DECREASED 8 0.0009
384 MYOPATHY 8 0.0009
385 CARDIAC MURMUR 8 0.0009
386 BRADYPHRENIA 6 0.0009
387 HYDROCEPHALUS 5 0.0009
388 ANHEDONIA 24 0.0009
389 JAW DISORDER 5 0.0009
390 HEPATIC STEATOSIS 17 0.0009
391 HYPERKERATOSIS 5 0.0009
392 HYPERGLYCAEMIA 33 0.0009
393 ATRIOVENTRICULAR BLOCK 7 0.0009
394 HYPOTONIA 9 0.0009
395 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
396 SALIVARY HYPERSECRETION 9 0.0009
397 AGITATION 66 0.0009
398 INTRACRANIAL PRESSURE INCREASED 5 0.0009
399 QUALITY OF LIFE DECREASED 12 0.0009
400 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
401 PRURITUS 342 0.0009
402 METASTASES TO LYMPH NODES 6 0.0009
403 PYREXIA 307 0.0009
404 CYST 11 0.0009
405 SEROTONIN SYNDROME 17 0.0009
406 FURUNCLE 7 0.0009
407 HEART RATE DECREASED 31 0.0009
408 HYPERTENSION 187 0.0009
409 ARTHRALGIA 366 0.0009
410 DYSPNOEA 498 0.0009
411 ANAEMIA 167 0.0009
412 RENAL INJURY 26 0.0009
413 CARDIAC FAILURE CONGESTIVE 70 0.0009
414 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
415 OEDEMA 47 0.0009
416 HYPOAESTHESIA ORAL 13 0.0009
417 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
418 WOUND 24 0.0009
419 OXYGEN SATURATION DECREASED 48 0.0009
420 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
421 SKIN DISCOLOURATION 39 0.0008
422 LEUKOPENIA 42 0.0008
423 PULMONARY FIBROSIS 16 0.0008
424 ACUTE KIDNEY INJURY 127 0.0008
425 DERMATITIS BULLOUS 6 0.0008
426 BURSITIS 10 0.0008
427 OESOPHAGITIS 9 0.0008
428 ATRIAL FIBRILLATION 80 0.0008
429 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
430 CEREBRAL HAEMORRHAGE 29 0.0008
431 DIARRHOEA 522 0.0008
432 PULMONARY OEDEMA 36 0.0008
433 OSTEOPOROSIS 33 0.0008
434 EOSINOPHILIA 14 0.0008
435 TOXIC SKIN ERUPTION 8 0.0008
436 BRAIN OEDEMA 10 0.0008
437 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
438 PHOTOPSIA 5 0.0008
439 PROTEINURIA 15 0.0008
440 AORTIC ANEURYSM 6 0.0008
441 SLEEP APNOEA SYNDROME 15 0.0008
442 HYPERTHERMIA 6 0.0008
443 NEOPLASM 9 0.0008
444 GLAUCOMA 15 0.0008
445 THERAPY NON-RESPONDER 35 0.0008
446 POOR QUALITY DRUG ADMINISTERED 5 0.0008
447 PALLOR 21 0.0008
448 VERTIGO 47 0.0008
449 PHARMACEUTICAL PRODUCT COMPLAINT 20 0.0008
450 ANGINA UNSTABLE 5 0.0008
451 RECTAL HAEMORRHAGE 33 0.0008
452 PETECHIAE 8 0.0008
453 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
454 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
455 TRANSFUSION 8 0.0008
456 AFFECTIVE DISORDER 6 0.0008
457 OSTEONECROSIS 25 0.0008
458 RESPIRATORY DISTRESS 21 0.0008
459 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
460 DRUG SCREEN POSITIVE 6 0.0008
461 BLOOD IRON DECREASED 9 0.0008
462 VOMITING 356 0.0008
463 SUDDEN DEATH 8 0.0008
464 RENAL CYST 6 0.0008
465 RESPIRATORY FAILURE 55 0.0008
466 CARDIAC FAILURE ACUTE 5 0.0007
467 HEPATIC ENCEPHALOPATHY 7 0.0007
468 CEREBROVASCULAR ACCIDENT 127 0.0007
469 DIARRHOEA HAEMORRHAGIC 7 0.0007
470 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 39 0.0007
471 STENT PLACEMENT 6 0.0007
472 URINARY INCONTINENCE 22 0.0007
473 POSTOPERATIVE WOUND INFECTION 5 0.0007
474 SHOCK 17 0.0007
475 PERICARDIAL EFFUSION 17 0.0007
476 ABNORMAL LOSS OF WEIGHT 5 0.0007
477 DISORIENTATION 29 0.0007
478 WOUND INFECTION 8 0.0007
479 ABASIA 18 0.0007
480 HYPOTENSION 146 0.0007
481 OSTEONECROSIS OF JAW 18 0.0007
482 RESPIRATORY ARREST 20 0.0007
483 HYPERCHOLESTEROLAEMIA 7 0.0007
484 SINUS BRADYCARDIA 7 0.0007
485 INTERSTITIAL LUNG DISEASE 35 0.0007
486 GASTRITIS 19 0.0007
487 METABOLIC ACIDOSIS 23 0.0007
488 EXTRASYSTOLES 5 0.0007
489 MALAISE 313 0.0007
490 MUSCULOSKELETAL CHEST PAIN 11 0.0007
491 CARDIAC FAILURE 57 0.0007
492 CARDIOVASCULAR DISORDER 18 0.0007
493 BLOOD PRESSURE FLUCTUATION 17 0.0007
494 HAND FRACTURE 5 0.0007
495 CIRCULATORY COLLAPSE 12 0.0007
496 RESPIRATORY DISORDER 21 0.0007
497 FATIGUE 544 0.0007
498 BRADYCARDIA 37 0.0007
499 APHASIA 21 0.0007
500 DIABETES MELLITUS 53 0.0007
501 HIATUS HERNIA 9 0.0007
502 OBESITY 11 0.0007
503 PLATELET COUNT INCREASED 9 0.0007
504 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
505 BLOOD SODIUM DECREASED 13 0.0007
506 FAECES SOFT 5 0.0007
507 POST PROCEDURAL HAEMORRHAGE 8 0.0007
508 SPLENOMEGALY 8 0.0007
509 TOOTH INFECTION 9 0.0007
510 PULMONARY CONGESTION 9 0.0007
511 PNEUMONIA 221 0.0007
512 ORAL DISORDER 5 0.0007
513 SOPOR 9 0.0007
514 MUSCLE TIGHTNESS 11 0.0007
515 HEADACHE 425 0.0007
516 MYOCARDIAL INFARCTION 118 0.0007
517 THERAPEUTIC RESPONSE DECREASED 41 0.0007
518 HERNIA 13 0.0007
519 TENDERNESS 7 0.0007
520 CHOLECYSTITIS 8 0.0007
521 PULMONARY MASS 10 0.0007
522 FLUID RETENTION 34 0.0007
523 HYDRONEPHROSIS 5 0.0007
524 GASTROENTERITIS VIRAL 12 0.0007
525 RED BLOOD CELL COUNT DECREASED 19 0.0007
526 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
527 MUSCULAR WEAKNESS 75 0.0007
528 PNEUMONIA BACTERIAL 6 0.0007
529 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
530 BLOOD GLUCOSE ABNORMAL 12 0.0006
531 CHEST PAIN 120 0.0006
532 HAEMOLYSIS 5 0.0006
533 CONJUNCTIVITIS 12 0.0006
534 RENAL DISORDER 30 0.0006
535 DEFORMITY 6 0.0006
536 PLEURAL EFFUSION 39 0.0006
537 BALANCE DISORDER 55 0.0006
538 DENTAL CARIES 7 0.0006
539 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
540 BLOOD PRESSURE DECREASED 42 0.0006
541 FEAR 17 0.0006
542 HYPERTENSIVE CRISIS 7 0.0006
543 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
544 EPISTAXIS 47 0.0006
545 INTENTIONAL PRODUCT MISUSE 55 0.0006
546 MALNUTRITION 7 0.0006
547 CHOLESTASIS 12 0.0006
548 SKIN INFECTION 7 0.0006
549 HYPERTHYROIDISM 9 0.0006
550 DYSPEPSIA 61 0.0006
551 EAR PAIN 12 0.0006
552 NAUSEA 488 0.0006
553 CHOLELITHIASIS 20 0.0006
554 HICCUPS 5 0.0006
555 DEMENTIA 17 0.0006
556 LIGAMENT SPRAIN 6 0.0006
557 DRUG LEVEL INCREASED 10 0.0006
558 HAEMOGLOBIN DECREASED 62 0.0006
559 BONE DISORDER 11 0.0006
560 VASCULITIS 7 0.0006
561 INFLAMMATION 31 0.0006
562 PNEUMONIA ASPIRATION 15 0.0006
563 COAGULOPATHY 10 0.0006
564 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
565 JAUNDICE 16 0.0006
566 TASTE DISORDER 12 0.0006
567 BACTERAEMIA 7 0.0006
568 MOTOR DYSFUNCTION 6 0.0006
569 MACULAR DEGENERATION 7 0.0006
570 POLYNEUROPATHY 7 0.0006
571 WRIST FRACTURE 7 0.0006
572 LIMB DISCOMFORT 18 0.0006
573 NEUROPATHY PERIPHERAL 55 0.0006
574 WEIGHT FLUCTUATION 6 0.0006
575 PANCYTOPENIA 32 0.0006
576 LUNG DISORDER 28 0.0006
577 RENAL IMPAIRMENT 48 0.0006
578 CARPAL TUNNEL SYNDROME 8 0.0006
579 DEEP VEIN THROMBOSIS 37 0.0006
580 GROIN PAIN 5 0.0006
581 INJURY 40 0.0006
582 NEPHROLITHIASIS 26 0.0006
583 PAIN IN JAW 16 0.0006
584 FLATULENCE 32 0.0006
585 DIALYSIS 8 0.0006
586 EXTRAPYRAMIDAL DISORDER 14 0.0006
587 TOOTH EXTRACTION 7 0.0006
588 HEREDITARY ANGIOEDEMA 6 0.0006
589 PARALYSIS 8 0.0006
590 GOUT 10 0.0006
591 LOSS OF LIBIDO 5 0.0006
592 ANAL INCONTINENCE 5 0.0006
593 LACTIC ACIDOSIS 18 0.0006
594 BLOOD BILIRUBIN INCREASED 15 0.0006
595 ALANINE AMINOTRANSFERASE INCREASED 34 0.0006
596 SPEECH DISORDER 29 0.0006
597 PAIN IN EXTREMITY 163 0.0006
598 TOOTHACHE 10 0.0006
599 UPPER LIMB FRACTURE 11 0.0006
600 INJECTION SITE IRRITATION 7 0.0005
601 FEMUR FRACTURE 17 0.0005
602 APATHY 8 0.0005
603 HYPOPHAGIA 14 0.0005
604 EXOSTOSIS 5 0.0005
605 BLOOD GLUCOSE FLUCTUATION 6 0.0005
606 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
607 STAPHYLOCOCCAL INFECTION 18 0.0005
608 THROMBOCYTOPENIA 61 0.0005
609 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
610 SEDATION 14 0.0005
611 FACE OEDEMA 9 0.0005
612 BLOOD CALCIUM DECREASED 6 0.0005
613 FLANK PAIN 5 0.0005
614 DEHYDRATION 71 0.0005
615 LOSS OF CONSCIOUSNESS 68 0.0005
616 TOOTH LOSS 11 0.0005
617 PALPITATIONS 62 0.0005
618 NIGHT SWEATS 17 0.0005
619 FOOT FRACTURE 10 0.0005
620 ABDOMINAL DISTENSION 55 0.0005
621 SCAR 9 0.0005
622 MOUTH ULCERATION 11 0.0005
623 OSTEOARTHRITIS 22 0.0005
624 LUNG INFECTION 8 0.0005
625 EJECTION FRACTION DECREASED 8 0.0005
626 PNEUMONITIS 14 0.0005
627 VISUAL ACUITY REDUCED 17 0.0005
628 HYPOXIA 18 0.0005
629 COLD SWEAT 9 0.0005
630 FAECES DISCOLOURED 11 0.0005
631 HOSPICE CARE 5 0.0005
632 DIVERTICULITIS 14 0.0005
633 RHABDOMYOLYSIS 21 0.0005
634 ROAD TRAFFIC ACCIDENT 21 0.0005
635 BRONCHITIS 37 0.0005
636 SPINAL FRACTURE 10 0.0005
637 BLOOD POTASSIUM DECREASED 15 0.0005
638 BLISTER 28 0.0005
639 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
640 JOINT STIFFNESS 13 0.0005
641 PELVIC PAIN 9 0.0005
642 BONE PAIN 29 0.0005
643 RASH MACULO-PAPULAR 11 0.0005
644 HYPOTHERMIA 5 0.0005
645 FIBROMYALGIA 12 0.0005
646 SINUS TACHYCARDIA 7 0.0005
647 WEIGHT DECREASED 137 0.0005
648 BRONCHOSPASM 7 0.0005
649 DISEASE PROGRESSION 58 0.0005
650 CONVULSION 28 0.0005
651 CONFUSIONAL STATE 79 0.0005
652 RASH MACULAR 17 0.0005
653 ILEUS 6 0.0005
654 FLUID OVERLOAD 7 0.0005
655 URINARY TRACT INFECTION 82 0.0005
656 NERVOUS SYSTEM DISORDER 15 0.0005
657 URINARY RETENTION 16 0.0005
658 DYSSTASIA 14 0.0005
659 INJECTION SITE DISCOMFORT 5 0.0005
660 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
661 ANXIETY 134 0.0005
662 CARDIAC DISORDER 44 0.0005
663 GASTROINTESTINAL DISORDER 42 0.0005
664 BODY HEIGHT DECREASED 5 0.0005
665 GASTRIC DISORDER 16 0.0005
666 BREAST CANCER METASTATIC 5 0.0005
667 DECREASED ACTIVITY 5 0.0005
668 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
669 HYPONATRAEMIA 26 0.0005
670 HAEMORRHOIDS 9 0.0005
671 AMNESIA 30 0.0005
672 WEIGHT INCREASED 103 0.0005
673 SEPTIC SHOCK 20 0.0005
674 MOBILITY DECREASED 33 0.0005
675 DYSGEUSIA 34 0.0005
676 EYE SWELLING 17 0.0005
677 INFECTION 66 0.0005
678 METASTASES TO LIVER 8 0.0005
679 PERIPHERAL SWELLING 70 0.0005
680 BLOOD PRESSURE ABNORMAL 9 0.0005
681 FOOT DEFORMITY 5 0.0005
682 BLOOD CHOLESTEROL INCREASED 21 0.0005
683 NERVE INJURY 5 0.0004
684 CARDIAC ARREST 37 0.0004
685 LIVER FUNCTION TEST ABNORMAL 13 0.0004
686 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
687 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
688 ABSCESS 7 0.0004
689 MICTURITION URGENCY 5 0.0004
690 SENSORY DISTURBANCE 7 0.0004
691 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
692 COORDINATION ABNORMAL 6 0.0004
693 BACTERIAL INFECTION 8 0.0004
694 DYSPHONIA 25 0.0004
695 BLINDNESS UNILATERAL 6 0.0004
696 HALLUCINATION 32 0.0004
697 LYMPHOPENIA 6 0.0004
698 GENERAL PHYSICAL HEALTH DETERIORATION 49 0.0004
699 UNEVALUABLE EVENT 32 0.0004
700 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
701 TREMOR 70 0.0004
702 ATAXIA 5 0.0004
703 HYPOAESTHESIA 63 0.0004
704 DEAFNESS 11 0.0004
705 MYOCLONUS 5 0.0004
706 SKIN CANCER 9 0.0004
707 EYE PRURITUS 14 0.0004
708 BLOOD GLUCOSE DECREASED 20 0.0004
709 TYPE 2 DIABETES MELLITUS 14 0.0004
710 ANOSMIA 6 0.0004
711 INJECTION SITE HAEMATOMA 6 0.0004
712 PRESCRIBED OVERDOSE 8 0.0004
713 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
714 GASTROENTERITIS 6 0.0004
715 DYSPHAGIA 39 0.0004
716 HEAD INJURY 13 0.0004
717 ACCIDENTAL OVERDOSE 15 0.0004
718 FEELING HOT 25 0.0004
719 GAIT DISTURBANCE 78 0.0004
720 WHEEZING 24 0.0004
721 SINUS DISORDER 8 0.0004
722 HYPERHIDROSIS 52 0.0004
723 MUSCLE SPASMS 74 0.0004
724 TREATMENT NONCOMPLIANCE 22 0.0004
725 HAEMORRHAGE 42 0.0004
726 LOCAL SWELLING 7 0.0004
727 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
728 THROAT IRRITATION 18 0.0004
729 PARAESTHESIA 63 0.0004
730 ABDOMINAL DISCOMFORT 67 0.0004
731 SWELLING FACE 26 0.0004
732 HAEMATOCHEZIA 22 0.0004
733 LACRIMATION INCREASED 12 0.0004
734 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
735 IMPAIRED HEALING 13 0.0004
736 MEDICATION ERROR 22 0.0004
737 EYE DISORDER 13 0.0004
738 ILL-DEFINED DISORDER 24 0.0004
739 FEEDING DISORDER 8 0.0004
740 DEVICE FAILURE 6 0.0004
741 BONE MARROW FAILURE 8 0.0004
742 HEART RATE INCREASED 39 0.0004
743 HEPATIC CYTOLYSIS 5 0.0004
744 GALLBLADDER DISORDER 7 0.0004
745 INTRAOCULAR PRESSURE INCREASED 5 0.0004
746 GAIT INABILITY 13 0.0004
747 OFF LABEL USE 340 0.0004
748 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
749 ANKLE FRACTURE 6 0.0004
750 PERITONITIS 8 0.0004
751 ANGIOEDEMA 17 0.0004
752 RESPIRATORY TRACT INFECTION 10 0.0004
753 HYPERSOMNIA 11 0.0004
754 NODULE 5 0.0004
755 JOINT SWELLING 46 0.0004
756 SICKLE CELL ANAEMIA WITH CRISIS 6 0.0004
757 PRODUCTIVE COUGH 18 0.0004
758 BLOOD GLUCOSE INCREASED 71 0.0004
759 HYPOTHYROIDISM 12 0.0004
760 CONDITION AGGRAVATED 114 0.0004
761 DIABETIC KETOACIDOSIS 9 0.0004
762 HAIR TEXTURE ABNORMAL 5 0.0004
763 HIP FRACTURE 12 0.0004
764 PRURITUS GENERALISED 8 0.0004
765 BLOOD URINE PRESENT 7 0.0004
766 LYMPHADENOPATHY 13 0.0004
767 DRUG TOXICITY 5 0.0004
768 IMPAIRED GASTRIC EMPTYING 5 0.0004
769 HEPATIC FAILURE 11 0.0004
770 ERYTHEMA 75 0.0004
771 ORAL DISCOMFORT 5 0.0004
772 APHONIA 5 0.0004
773 DRUG INEFFECTIVE 472 0.0004
774 NECK PAIN 20 0.0004
775 MASS 5 0.0004
776 C-REACTIVE PROTEIN INCREASED 13 0.0004
777 ORAL PAIN 8 0.0004
778 PERICARDITIS 6 0.0004
779 KIDNEY INFECTION 7 0.0004
780 PANCREATITIS ACUTE 8 0.0004
781 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
782 PAIN 218 0.0004
783 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
784 CONSTIPATION 77 0.0004
785 BACK PAIN 82 0.0004
786 SWOLLEN TONGUE 11 0.0004
787 SINUSITIS 36 0.0004
788 ERECTILE DYSFUNCTION 9 0.0004
789 TREATMENT FAILURE 29 0.0003
790 PLATELET COUNT DECREASED 37 0.0003
791 VISUAL IMPAIRMENT 43 0.0003
792 DYSARTHRIA 13 0.0003
793 MUSCULOSKELETAL PAIN 18 0.0003
794 CHEST DISCOMFORT 35 0.0003
795 PANCREATITIS 18 0.0003
796 DEPRESSED MOOD 18 0.0003
797 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
798 PULMONARY EMBOLISM 32 0.0003
799 POLLAKIURIA 14 0.0003
800 THROMBOSIS 27 0.0003
801 LIMB INJURY 9 0.0003
802 ARTHRITIS 26 0.0003
803 EATING DISORDER 7 0.0003
804 RESTLESSNESS 12 0.0003
805 IRRITABLE BOWEL SYNDROME 7 0.0003
806 DYSURIA 12 0.0003
807 DEVICE RELATED INFECTION 5 0.0003
808 LYMPHOMA 5 0.0003
809 WHITE BLOOD CELL COUNT DECREASED 35 0.0003
810 EMOTIONAL DISTRESS 39 0.0003
811 DRY MOUTH 26 0.0003
812 NIGHTMARE 11 0.0003
813 PRODUCT USE COMPLAINT 5 0.0003
814 NEUTROPENIA 43 0.0003
815 PNEUMOTHORAX 5 0.0003
816 TOOTH DISORDER 7 0.0003
817 PREMATURE DELIVERY 5 0.0003
818 INCREASED APPETITE 6 0.0003
819 RASH ERYTHEMATOUS 15 0.0003
820 BURNING SENSATION 22 0.0003
821 LETHARGY 18 0.0003
822 HEPATITIS 8 0.0003
823 ERUCTATION 6 0.0003
824 DEPRESSION 70 0.0003
825 SURGERY 18 0.0003
826 MULTIPLE FRACTURES 5 0.0003
827 FEBRILE NEUTROPENIA 20 0.0003
828 CYTOMEGALOVIRUS INFECTION 5 0.0003
829 MEMORY IMPAIRMENT 41 0.0003
830 FULL BLOOD COUNT DECREASED 6 0.0003
831 FEELING ABNORMAL 71 0.0003
832 OCULAR HYPERAEMIA 14 0.0003
833 DRUG ADMINISTRATION ERROR 9 0.0003
834 THERAPY CESSATION 15 0.0003
835 OVERDOSE 63 0.0003
836 RIB FRACTURE 6 0.0003
837 COLITIS 11 0.0003
838 ABNORMAL DREAMS 8 0.0003
839 NEURALGIA 7 0.0003
840 INFUSION RELATED REACTION 19 0.0003
841 DERMATITIS 6 0.0003
842 TARDIVE DYSKINESIA 8 0.0003
843 LYMPHOCYTE COUNT DECREASED 5 0.0003
844 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
845 RETCHING 6 0.0003
846 AGEUSIA 7 0.0003
847 STOMATITIS 17 0.0003
848 DRUG INTOLERANCE 27 0.0003
849 COGNITIVE DISORDER 13 0.0003
850 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
851 MENTAL DISORDER 12 0.0003
852 DRUG EFFECT INCOMPLETE 10 0.0003
853 RESTLESS LEGS SYNDROME 5 0.0003
854 PANIC ATTACK 10 0.0003
855 PRODUCT USE IN UNAPPROVED INDICATION 68 0.0003
856 MUSCULOSKELETAL STIFFNESS 24 0.0003
857 DRUG RESISTANCE 7 0.0003
858 LABORATORY TEST ABNORMAL 8 0.0003
859 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
860 DYSKINESIA 11 0.0003
861 TRANSAMINASES INCREASED 6 0.0003
862 SNEEZING 6 0.0003
863 MUCOSAL INFLAMMATION 7 0.0003
864 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
865 HEPATIC CIRRHOSIS 5 0.0003
866 CHROMATURIA 6 0.0003
867 INTESTINAL OBSTRUCTION 10 0.0003
868 INTENTIONAL OVERDOSE 17 0.0003
869 HEPATIC ENZYME INCREASED 18 0.0003
870 PRODUCT AVAILABILITY ISSUE 6 0.0003
871 ADVERSE EVENT 24 0.0003
872 POST PROCEDURAL COMPLICATION 5 0.0003
873 LOWER LIMB FRACTURE 5 0.0003
874 DISTURBANCE IN ATTENTION 14 0.0003
875 EMOTIONAL DISORDER 8 0.0003
876 THROAT TIGHTNESS 7 0.0003
877 GYNAECOMASTIA 8 0.0003
878 SWELLING 24 0.0003
879 SKIN FISSURES 5 0.0003
880 INFLUENZA LIKE ILLNESS 21 0.0003
881 DISABILITY 5 0.0003
882 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
883 PROCEDURAL PAIN 7 0.0003
884 FEELING COLD 7 0.0003
885 ABORTION SPONTANEOUS 10 0.0002
886 MOVEMENT DISORDER 8 0.0002
887 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
888 LIVER DISORDER 11 0.0002
889 MENTAL IMPAIRMENT 6 0.0002
890 LIVER INJURY 6 0.0002
891 LUNG NEOPLASM MALIGNANT 10 0.0002
892 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
893 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
894 PRODUCT DOSE OMISSION ISSUE 71 0.0002
895 VIRAL INFECTION 8 0.0002
896 AGGRESSION 12 0.0002
897 URTICARIA 40 0.0002
898 NASAL CONGESTION 14 0.0002
899 WITHDRAWAL SYNDROME 10 0.0002
900 JOINT INJURY 5 0.0002
901 ANAPHYLACTIC SHOCK 6 0.0002
902 HYPOACUSIS 10 0.0002
903 RASH GENERALISED 6 0.0002
904 RASH 99 0.0002
905 EYE IRRITATION 13 0.0002
906 TOXICITY TO VARIOUS AGENTS 38 0.0002
907 SKIN EXFOLIATION 19 0.0002
908 FREQUENT BOWEL MOVEMENTS 6 0.0002
909 HEART RATE IRREGULAR 5 0.0002
910 DRY EYE 11 0.0002
911 CRYING 8 0.0002
912 MOOD ALTERED 6 0.0002
913 MIGRAINE 21 0.0002
914 DRUG DEPENDENCE 35 0.0002
915 RHINORRHOEA 14 0.0002
916 FLUSHING 22 0.0002
917 ARTHROPATHY 12 0.0002
918 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
919 NASOPHARYNGITIS 39 0.0002
920 NERVOUSNESS 11 0.0002
921 PRODUCT PRESCRIBING ERROR 5 0.0002
922 NEOPLASM MALIGNANT 14 0.0002
923 SUICIDAL IDEATION 19 0.0002
924 UNDERDOSE 15 0.0002
925 DRUG EFFECT DECREASED 11 0.0002
926 ILLNESS 21 0.0002
927 RASH PRURITIC 11 0.0002
928 ADVERSE DRUG REACTION 18 0.0002
929 PREMATURE BABY 6 0.0002
930 SLEEP DISORDER 14 0.0002
931 DISCOMFORT 12 0.0002
932 EPILEPSY 6 0.0002
933 ALOPECIA 38 0.0002
934 HYPERSENSITIVITY 35 0.0002
935 EAR INFECTION 5 0.0002
936 DRY SKIN 25 0.0002
937 DEATH 161 0.0002
938 HOT FLUSH 14 0.0002
939 PAIN OF SKIN 5 0.0002
940 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
941 INFLUENZA 20 0.0002
942 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
943 ANGER 6 0.0002
944 EXPOSURE DURING PREGNANCY 11 0.0002
945 NEUTROPHIL COUNT DECREASED 7 0.0002
946 PRODUCT DOSE OMISSION 11 0.0002
947 PSORIASIS 22 0.0002
948 ASTHMA 19 0.0002
949 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
950 IRRITABILITY 10 0.0002
951 DRUG DOSE OMISSION 27 0.0002
952 COVID-19 28 0.0002
953 RHEUMATOID ARTHRITIS 18 0.0002
954 CYSTITIS 5 0.0002
955 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
956 ECZEMA 8 0.0002
957 FUNGAL INFECTION 5 0.0001
958 SUICIDE ATTEMPT 9 0.0001
959 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
960 DISEASE RECURRENCE 7 0.0001
961 NEOPLASM PROGRESSION 5 0.0001
962 PRODUCT QUALITY ISSUE 18 0.0001
963 SEIZURE 15 0.0001
964 PLASMA CELL MYELOMA 5 0.0001
965 PRODUCT USE ISSUE 24 0.0001
966 ANAPHYLACTIC REACTION 7 0.0001
967 ABNORMAL BEHAVIOUR 5 0.0001
968 EXTRA DOSE ADMINISTERED 5 0.0001
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
970 PSORIATIC ARTHROPATHY 5 0.0001
971 INJECTION SITE PAIN 37 0.0001
972 HOSPITALISATION 18 0.0001
973 INJECTION SITE HAEMORRHAGE 9 0.0001
974 SKIN BURNING SENSATION 8 0.0001
975 INCORRECT DOSE ADMINISTERED 25 0.0001
976 INJECTION SITE PRURITUS 7 0.0001
977 INJECTION SITE BRUISING 8 0.0001
978 OROPHARYNGEAL PAIN 9 0.0001
979 ACNE 7 0.0001
980 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
981 THERAPY INTERRUPTED 6 0.0001
982 INJECTION SITE ERYTHEMA 10 0.0001
983 INJECTION SITE SWELLING 6 0.0001
984 COMPLETED SUICIDE 6 0.0001
985 DEVICE MALFUNCTION 5 0.0001
986 DRUG WITHDRAWAL SYNDROME 6 0.0001
987 DEVICE ISSUE 6 0.0001
988 BREAST CANCER 6 0.0001
989 PROSTATE CANCER 5 0.0001
990 NO ADVERSE EVENT 11 0.0001